Technical Analysis for LBPH - Longboard Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 36.00 -0.61% -0.22
LBPH closed down 0.61 percent on Thursday, July 18, 2024, on 1.18 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Aug 1
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion -0.61%
Overbought Stochastic Strength -0.61%
Gapped Down Weakness -0.61%
New 52 Week Closing High Bullish -8.86%
Calm After Storm Range Contraction -8.86%
NR7 Range Contraction -8.86%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 19 hours ago
Down 1% about 21 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Fell Below 10 DMA about 21 hours ago
Reversed from Up about 21 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals, Inc. was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. The company was founded in 2020 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Neuroscience Epilepsy Psychiatry Amyotrophic Lateral Sclerosis Neurophysiology Neurology Nervous System Clinical Trial Product Neurological Diseases

Is LBPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.48
52 Week Low 3.6
Average Volume 524,515
200-Day Moving Average 16.72
50-Day Moving Average 23.86
20-Day Moving Average 30.45
10-Day Moving Average 36.32
Average True Range 2.83
RSI (14) 65.52
ADX 44.94
+DI 34.05
-DI 13.92
Chandelier Exit (Long, 3 ATRs) 31.98
Chandelier Exit (Short, 3 ATRs) 26.77
Upper Bollinger Bands 44.32
Lower Bollinger Band 16.58
Percent B (%b) 0.7
BandWidth 91.09
MACD Line 4.52
MACD Signal Line 4.14
MACD Histogram 0.3778
Fundamentals Value
Market Cap 1.19 Billion
Num Shares 32.9 Million
EPS -2.43
Price-to-Earnings (P/E) Ratio -14.81
Price-to-Sales 0.00
Price-to-Book 13.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.87
Resistance 3 (R3) 40.21 39.26 39.23
Resistance 2 (R2) 39.26 38.27 39.09 39.01
Resistance 1 (R1) 37.63 37.67 37.16 37.29 38.79
Pivot Point 36.68 36.68 36.44 36.51 36.68
Support 1 (S1) 35.05 35.69 34.58 34.71 33.21
Support 2 (S2) 34.10 35.09 33.93 32.99
Support 3 (S3) 32.47 34.10 32.78
Support 4 (S4) 32.13